COPD in Japan: The Nippon COPD Epidemiology study

Respirology

Volumn 9, Issue 4, 2004, Pages 458-465

  Fukuchi, Yoshinosuke ^a   Nishimura, Masaharu ^b   Ichinose, Masakazu ^c   Adachi, Mitsuru ^d   Nagai, Atsushi ^e   Kuriyama, Takayuki ^f   Takahashi, Keiji ^g   Nishimura, Koichi ^h   Ishioka, Shinichi ⁱ   Aizawa, Hisamichi ^j   Zaher, Carol ^k  

^a JUNTENDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

^d SHOWA UNIVERSITY   (Japan)

^e TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^f CHIBA UNIVERSITY   (Japan)

^g KANAZAWA MEDICAL UNIVERSITY   (Japan)

^h KYOTO UNIVERSITY   (Japan)

ⁱ HIROSHIMA UNIVERSITY   (Japan)

^j National Hospital Organization   (Japan)

^k Cerner Health Insights   (United States)

more..

Author keywords

Airflow limitation; Airway obstruction; Chronic obstructive pulmonary disease; Epidemiology; Prevalence; Smoking

Indexed keywords

ADULT; AGED; AGING; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH CARE COST; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; OCCUPATIONAL EXPOSURE; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY AIRFLOW; RISK FACTOR; SEX DIFFERENCE; SMOKING; SPIROMETRY;

ADULT; AGE DISTRIBUTION; AGED; COMORBIDITY; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGRESSION ANALYSIS; SEX DISTRIBUTION; SMOKING;

EID: 19944430705     PISSN: 13237799     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2004.00637.x     Document Type: Article

References (33)

1. Hurd S. The impact of COPD on lung health worldwide: epidemiology and incidence. Chest 2000; 117: 1S-4S.
2. Murray CJL, Lopez AD. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Harvard University Press, Cambridge, 1996.
3. Calverley PM. COPD: early detection and intervention. Chest 2000; 117: 365S-71S.
4. Global Initiative for Chronic Obstructive Lung Disease. GOLD Workshop Updated 2003. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Available from URL: http://www.goldcopd. com. Updated 2003 (accessed 17 July 2003).
5. World Health Organization. The Tobacco Epidemic: A Global Public Health Emergency. Tobacco Alert April 1996.
6. Shin C, In KH, Shim JJ et al. Prevalence and correlates of airway obstruction in a community-based sample of adults. Chest 2003; 123: 1924-31.
7. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch. Intern. Med. 2000; 160: 1683-9.
8. Halbert RJ, Isonaka S, George D, Iqbal A. Interpreting COPD prevalence estimates: what is the true burden of disease? Chest 2003; 123: 1684-92.
9. Lange P, Groth S, Nyboe J et al. Chronic obstructive lung disease in Copenhagen: cross-sectional epidemiological aspects. J. Intern. Med. 1989; 226: 25-32.
10. Statistics Bureau: Ministry of Public Management, Home Affairs, Posts and Telecommunications. Population Estimates for the Year 2000, Ministry of Public Management, Home Affairs, Posts and Telecommunications.
11. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1995; 152: S77-121.
12. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur. Respir. J. 2004; 23: 932-46.
13. Reference values for lung function in the Japanese: recording of normal lung function from 14 institutes in Japan. Jpn. J. Thoracic Dis. 1993; 31: 421-7.
14. Tashkin DP, Clark VA, Coulson AH et al. The UCLA population studies of chronic obstructive respiratory disease. VIII. Effects of smoking cessation on lung function: a prospective study of a free-living population. Am. Rev. Respir. Dis. 1984; 130: 707-15.
15. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br. Med. J. 1977; 1: 1645-8.
16. Ashley F, Kannel WB, Sorlie PD, Masson R. Pulmonary function: relation to aging, cigarette habit, and mortality. Ann. Intern. Med. 1975; 82: 739-45.
17. Pandey MR. Prevalence of chronic bronchitis in a rural community of the Hill Region of Nepal. Thorax 1984; 39: 331-6.
18. Melbostad E, Eduard W, Magnus P. Chronic bronchitis in farmers. Scand. J. Work Environ. Health 1997; 23: 271-80.
19. Hnizdo E, Sullivan PA, Bang KM, Wagner G. Association between chronic obstructive pulmonary disease and employment by industry and occupation in the US population: a study of data from the Third National Health and Nutrition Examination Survey. Am. J. Epidemiol. 2002; 156: 738-46.
20. Pena VS, Miravitlles M, Gabriel R et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest 2000; 118: 981-9.
21. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Surveillance Summaries, August 2, 2002. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWR 2002; 51: 1-16.
22. Chapman KR, Tashkin DP, Pye DJ. Gender bias in the diagnosis of COPD. Chest 2001; 119: 1691-5.
23. Dodge R, Cline MG, Burrows B. Comparisons of asthma, emphysema, and chronic bronchitis diagnoses in a general population sample. Am. Rev. Respir. Dis. 1986; 133: 981-6.
24. Tatsumi K. Epidemiological survey of chronic obstructive pulmonary disease in Japan. Respirology 2001; 6: S27-33.
25. Buist AS, Vollmer WM, Wu Y et al. Effects of cigarette smoking on lung function in four population samples in the People's Republic of China. The PRC-US Cardiovascular and Cardiopulmonary Epidemiology Research Group. Am. J. Respir. Crit. Care Med. 1995; 151: 1393-400.
26. Marcus EB, Buist AS, Curb JD et al. Correlates of FEV1 and prevalence of pulmonary conditions in Japanese-American men. Am. Rev. Respir. Dis. 1988; 138: 1398-404.
27. Viegi G, Pedreschi M, Pistelli F et al. Prevalence of airways obstruction in a general population: European Respiratory Society vs American Thoracic Society definition. Chest 2000; 117: 339S-45S.
28. The COPD Guidelines Group of the Standards of Care Committee of the BTS. BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997; 52: S1-28.
29. Masoli M, Fabian D, Holt S, Beasley R. Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004; 59: 469-78.
30. Onuki T, Nitta S. Indications for lung transplantation and its selection of the candidates in Japan. Nippon Rinsho 1999; 57: 2090-4 (in Japanese).
31. Nukiwa T, Seyama K, Takahashi H, Kira S. Alpha 1-antitrypsin genes in patients with alpha 1AT deficiency in Japan: mutational analysis and allelic background. Nihon Kyobu Shikkan Gakkai Zasshi 1992; 30: 1420-6 (in Japanese).
32. Seyama K. State of alpha 1-antitrypsin deficiency in Japan. Respirology 2001; 6: S35-8.
33. http://www.stat.go.jp/data/kokusei/2000/kihon1/00/zuhyou/a004-1_1.xls